Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients

The American Journal of Medicine
B E KregerW R McCabe

Abstract

Clinical features and specific aspects of treatment were evaluated in 612 patients with gram-negative bacteremia observed over a 10 year period. Coagulation abnormalities or thrombocytopenia were observed in 64 per cent of the patients. Evidence of disseminated intravascular coagulation (DIC) was found in approximately 10 per cent of them but was of sufficient severity to be associated with subcutaneous or visceral bleeding in 3 per cent of them. The frequency of coagulation abnormalities, other than DIC, was greater in patients with more severe underlying disease but DIC occurred with similar frequency irrespective of the severity of underyling host disease. Coagulation abnormalities of all types were associated with increased fatality rates. Hypothermia was noted in 13 per cent of the patients at the onset of bacteremia but was transient and was not associated with increased fatality. Failure to mount a febrile response greater than 99.6 degrees F within the first 24 hours of bacteremia was associated with a significant increase in fatality rates. Prior corticosteroid therapy diminished the febrile response to bacteremia. Age, underlying host disease, granulocytopenia, congestive heart failure, diabetes mellitus, renal insuff...Continue Reading

Associated Clinical Trials

Aug 7, 2018·Jaime Daniel Mondragón Uribe

Citations

Dec 7, 2007·Intensive Care Medicine·R Phillip DellingerJean-Louis Vincent
Jan 5, 1996·Mechanisms of Ageing and Development·B S BenderS Taylor
Nov 15, 1989·Thrombosis Research·A E Schorer, J G White
Sep 21, 1991·Lancet·J Cohen, M P Glauser
Jan 1, 1990·Experimental Gerontology·S F Bradley, C A Kauffman
Nov 1, 1985·Diagnostic Microbiology and Infectious Disease·J H Jorgensen
Nov 1, 1985·Diagnostic Microbiology and Infectious Disease·G V Doern
Sep 1, 1986·Diagnostic Microbiology and Infectious Disease·M P WeinsteinJ R Murphy
Aug 1, 1987·Diagnostic Microbiology and Infectious Disease·E BouzaM Rodríguez-Créixems
Sep 1, 1990·Diagnostic Microbiology and Infectious Disease·T Calandra, M P Glauser
Jul 6, 2004·Annales Françaises D'anesthèsie Et De Rèanimation·P MontraversA Cargeac
Dec 24, 2003·Journal of Critical Care·Jean Claude LacheradeUNKNOWN French and Canadian ICU Directors Groups
May 30, 1998·Lancet·M E Astiz, E C Rackow
Oct 15, 2003·The Journal of Infection·Charalambos A GogosHarry P Bassaris
Jun 6, 1997·Health Policy·J Mason, M Drummond
Nov 19, 2003·The Journal of Hospital Infection·R MastertonG Park
Feb 1, 1983·American Journal of Infection Control·E S Wong
Apr 18, 2000·Critical Care Clinics·D Simon, G Trenholme
Mar 5, 1999·The Journal of Arthroplasty·L M BreakwellC Austin
Oct 6, 2001·Pediatric Neurology·N L Antunes
Jun 1, 1996·Infectious Disease Clinics of North America·J F Toney, M M Parker
Feb 12, 2002·European Journal of Internal Medicine·D TalonJ L. Dupond
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·J SchimkeR J Ulevitch
Jul 1, 1982·Annals of Surgery·R N GarrisonH C Polk
Jun 1, 1996·Annals of Surgery·K A KudskK B Renegar
Dec 24, 2009·Critical Care Medicine·Amisha V BarochiaPeter Q Eichacker
Jan 1, 1997·Microbiology and Immunology·T KirikaeD C Morrison
Dec 21, 2004·British Journal of Clinical Pharmacology·M LingvallR Broadbent
Nov 1, 1990·Journal of Veterinary Internal Medicine·E M Hardie, K Kruse-Elliott
May 1, 1988·Antimicrobial Agents and Chemotherapy·S HarkonenR Greenberg
Aug 1, 1991·Antimicrobial Agents and Chemotherapy·M M HuyckeM S Gilmore
Jun 1, 1994·Antimicrobial Agents and Chemotherapy·J M PrinsP Speelman
Jul 6, 2012·Clinical Microbiology Reviews·Pranita D TammaLisa L Maragakis
Feb 29, 2008·Journal of Clinical Microbiology·Stefan RiedelGary V Doern
Jan 9, 2003·Journal of Clinical Microbiology·Erik L MunsonGary V Doern

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.